Integrating innate and adaptive pathways in vaccine responses

$2,848,678U19FY2018AINIH

Rockefeller University, New York NY

Investigators

Linked publications & trials

Paper 39437779 Paper 39316623 Paper 39268652 Paper 39023559 Paper 37715951 Paper 37429907 Paper 37368240 Paper 37202422 Paper 37084725 Paper 36752204 Paper 36701425 Paper 36653360 Paper 36565698 Paper 36538032 Paper 36473496 Paper 36409896 Paper 36032981 Paper 35982682 Paper 35976993 Paper 35818364 Paper 35797920 Paper 35796685 Paper 35781671 Paper 35776090 Paper 35664993 Paper 35447027 Paper 35336960 Paper 35235456 Paper 35132412 Paper 35075455 Paper 35043109 Paper 35040666 Paper 35030645 Paper 35025672 Paper 34648371 Paper 34619745 Paper 34547765 Paper 34521836 Paper 34464594 Paper 34413139 Paper 34331873 Paper 34319348 Paper 34265243 Paper 34234131 Paper 34126625 Paper 34083490 Paper 34075373 Paper 33914041 Paper 33831141 Paper 33767397 Paper 33758864 Paper 33758856 Paper 33658717 Paper 33567448 Paper 33533915 Paper 33482248 Paper 33461210 Paper 33442697 Paper 33382968 Paper 33377023 Paper 33357464 Paper 33330867 Paper 33288661 Paper 33288645 Paper 33211088 Paper 33169014 Paper 33112236 Paper 33093202 Paper 32995782 Paper 32995758 Paper 32972996 Paper 32972995 Paper 32941787 Paper 32938700 Paper 32935095 Paper 32839788 Paper 32785687 Paper 32782358 Paper 32766586 Paper 32702737 Paper 32692348 Paper 32676593 Paper 32645326 Paper 32577658 Paper 32577645 Paper 32555388 Paper 32511384 Paper 32504577 Paper 32416070 Paper 32402275 Paper 32285199 Paper 32209664 Paper 32025908 Paper 32014647 Paper 31413072 Paper 31270247 Paper 31121434 Paper 30403995 Paper 30222771 Paper 30143481

Abstract

DESCRIPTION (provided by applicant): The goal of this program is to perform directed investigations into the evolution of lasting, protective Immune responses in humans in order to better understand the requirements of effective vaccines and adjuvants. This application is submitted to obtain funding for a Cooperative Center on Human Immunology at The Rockefeller University. Our program is highly integrated and is based on long-term, productive collaborations between the PIs on defining underlying principles of human immunology, utilizing the infrastructure of the Rockefeller University Hospital, the Zanvil Cohn Vaccine Center and the Rockefeller University Clinical and Translational Science Award (CTSA). The proposed research projects are designed as hypothesis-testing, mechanistic studies, examining novel aspects of the activation and regulation of human immune responses in the context of vaccination against infectious disease. The participating investigators are pioneers in identifying and characterizing basic mechanisms of the human immune response, having contributed to the initial characterizations of the dendritic cell, the diversity of IgG antibody effector functions ad description of Fc receptors as mediators of immunity, the development of the first models for study of the hepatitis C virus and the Identification of multiple HCV receptors. While significant progress in basic immunology research over the last three decades has resulted in numerous medical advances, a much more substantial understanding of coordinated molecular mechanisms involved in eliciting Immunity will be required to enable judicious vaccine design, particularly for diseases for which no vaccines currently exits. The objective of this proposal is o draw on the broad expertise in immunity and infectious diseases within the collaborating laboratories to define the contributions of critical components, such as dendritic cells, T follicuar helper cells, monocytes and immune complexes in the generation and maintenance of effective immune responses to infectious agents.

View original record on NIH RePORTER →